In one early example of this strategy, we used fly transgenic models to test the hypothesis that candidate Alzheimer's disease susceptibility genes modulate neurodegenerative phenotypes induced by expression of the human MAPT protein, responsible for the characteristic neurofibrillary tangle pathology (Shulman et al., 2011). The gene discussed is MAPT; the disease is early-onset autosomal dominant Alzheimer disease.